Related Experiment Video

Updated: Aug 8, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

[Cystic fibrosis: facing patient transition from the pediatrician to the internist]

Luis E Vega-Briceño1, Ernesto Guiraldes C, Ignacio Sánchez D

  • 1Secciones de Respiratorio Pediátrico, Respiratorio Pediátrico, Departamento de Pediatría, Pontificia Universidad Católica de Chile. levega@puc.cl

Revista Medica De Chile
|May 6, 2006
PubMed

Insights

Increased survival in cystic fibrosis (CF) patients leads to new complications. Early diagnosis and management, including antimicrobials and physiotherapy, are key for better outcomes in CF patients.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Genetics

Context:

  • Increased survival in cystic fibrosis (CF) patients presents new management challenges.
  • CF patients exhibit early inflammatory pulmonary changes and are susceptible to bacterial infections (Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa).
  • Disease presentation varies with age, with severe forms leading to early respiratory insufficiency.

Purpose:

  • To highlight the evolving landscape of cystic fibrosis (CF) complications.
  • To emphasize the importance of early diagnosis and comprehensive management strategies.
  • To underscore the need for coordinated, multidisciplinary care transition from pediatric to adult services.

Summary:

  • Advances in diagnostics and therapeutics improve CF patient survival and enable earlier detection.
  • Effective CF management requires timely antimicrobial selection, pancreatic enzyme supplementation, and early respiratory physiotherapy.
  • Recognizing CF progression as a continuous process necessitates flexible care transitions and integrated specialist communication.

Impact:

  • Improved patient outcomes and quality of life for individuals with cystic fibrosis.
  • Reduced burden of pulmonary and non-pulmonary complications in the growing CF population.
  • Enhanced understanding of CF management, guiding clinical practice and future research.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...